- For Some, ‘Tis the Season for Loneliness. Experts Offer Tips to Stay Connected
- Taking a GLP-1 Medication? Here’s Tips to Holiday Eating
- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
Chemo for Breast Cancer Erases Woman’s Fingerprints
A 65-year-old breast cancer patient ran into an unexpected problem with her bank: She was denied a transaction because her fingerprints had disappeared.
Reporting in the April 16 issue of the New England Journal of Medicine, doctors in Mexico said the woman’s unusual case was due to the effects of chemotherapy for an advanced breast cancer that had spread to the lungs.
A chemotherapy side effect called “hand-foot syndrome” appears to be tied to the fingerprint loss, wrote Drs. Yanin Chavarri-Guerra and Enrique Soto-Perez-de-Celis, of the Institute of Medical Science and Nutrition in Mexico City. They described the syndrome as “characterized by redness, swelling, and pain on the palms of the hands or soles of the feet.”
The patient in question experienced hand-foot syndrome that was so bad it interfered with everyday tasks, the two physicians said.
“Loss of fingerprints is a rare complication of chemotherapeutic agents that cause hand-foot syndrome,” added an expert in the United States, Dr. Stephanie Bernik.
“Skin sloughing and peeling with associated swelling is not so uncommon, but the occurrence to the extent that fingerprints may disappear is extremely unusual,” said Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City.
The good news for the patient was that the chemotherapy — a combination of capecitabine and bevacizumab — seemed to shrink the lung tumors, so the dosage was reduced. But while the hand-foot syndrome dissipated, the loss of fingerprints appears permanent, the doctors wrote.
“Usually the symptoms [of hand-foot syndrome, such as skin peeling] are reversible but apparently that was not the case with this patient,” Bernik said.
“Health care workers and patients need to be aware of this possible rare result of chemotherapy, especially in an age where use of fingerprints for identification is increasing,” she added.
The physicians noted that they provided the patient “with a letter explaining that the chemotherapy was responsible for her lack of fingerprints.”
More information
Find out more about breast cancer care at the American Cancer Society.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.